
A nationwide baby formula shortage has left many parents scrambling to find alternative sources for their little ones. The shortage is largely attributed to a recall of Similac and other formulas by Abbott Labs.
The recall was issued due to contamination concerns at an Abbott Labs manufacturing plant in Sturgis, Michigan. The plant was shut down for cleaning and inspection.
Parents are feeling the pinch, with many stores selling out of formula or limiting purchases to prevent hoarding. Some are even resorting to making their own baby food or seeking out online marketplaces.
Curious to learn more? Check out: Abbott Labs Recall
Allegations and Lawsuits
The allegations against Abbott Laboratories and Mead Johnson are serious. Plaintiffs claim that the companies failed to warn healthcare providers and parents about the risks of necrotizing enterocolitis (NEC) associated with their cow's milk-based formulas.
The lawsuits against Abbott Laboratories and Mead Johnson are based on negligence, product liability, and consumer fraud. The companies are accused of not providing sufficient warnings about the risks of NEC, promoting their formulas as safe and effective for premature infants without disclosing the potential dangers.
Explore further: Ripple Labs Wins Final Judgment in Xrp Case against Sec
Some of the key allegations include:
- Negligence: The companies are accused of negligence in their duty to ensure the safety of their products and provide adequate instructions for their safe use.
- Product Liability: The claims argue that Similac and Enfamil formulas are inherently dangerous when used as intended for feeding premature infants and that Abbott Laboratories and Mead Johnson should be held liable for the injuries and deaths resulting from NEC.
- Consumer Fraud: In some cases, plaintiffs assert that the companies engaged in deceptive marketing practices, promoting Similac as safe and effective for premature infants without disclosing the potential dangers.
These allegations have led to lawsuits seeking accountability, justice for affected families, and public awareness about the potential dangers of cow's milk-based formulas for preterm infants.
Allegations Against Mead Johnson
Mead Johnson, the manufacturer of Similac, has been accused of failing to warn healthcare providers and parents about the risks of NEC associated with their cow's milk-based formulas. This lack of warning allegedly contributed to the suffering and death of premature infants.
The company is accused of negligence in its duty to ensure the safety of its products and provide adequate instructions for their safe use. This negligence is a serious allegation that could have far-reaching consequences.
Plaintiffs also argue that Similac formulas are inherently dangerous when used as intended for feeding premature infants, and that Mead Johnson should be held liable for the injuries and deaths resulting from NEC.
The lawsuits against Mead Johnson are based on the following serious allegations:
- Negligence: Mead Johnson is accused of failing to ensure the safety of its products and provide adequate instructions for their safe use.
- Product Liability: The claims argue that Similac formulas are inherently dangerous when used as intended for feeding premature infants.
- Consumer Fraud: In some cases, plaintiffs assert that Mead Johnson engaged in deceptive marketing practices, promoting Similac as safe and effective for premature infants without disclosing the potential dangers.
Suit Filed Against Labs Over Nationwide Shortage
A shareholder derivative lawsuit has been filed against Abbott Laboratories over the nationwide baby formula shortage. The suit names the company, its CEO, and executive level leaders.
The lawsuit was filed in federal court after Abbott closed a Michigan infant formula manufacturing facility. The facility's closure contributed to the nationwide shortage.
A Chicago federal judge has substantially trimmed a derivative suit against Abbott Laboratories leaders. The suit accused them of concealing known safety issues related to recalled infant formula.
Cohen Milstein, a law firm, is co-lead counsel in a shareholder derivative lawsuit against Abbott Laboratories' board of directors. The lawsuit seeks to hold the board accountable for the baby formula contamination.
The lawsuit was filed in response to the nationwide infant formula shortage that occurred in winter 2022. The shortage was caused by a recall and the shutdown of one of Abbott's infant formula factories.
The cases in this litigation typically involve two defendants: Abbott and Mead Johnson.
Readers also liked: Abbott Labs Board of Directors
Recall and Compensation
Similac baby formula has not been recalled specifically for NEC risks, but it was part of a broader Abbott baby formula recall in 2022 due to potential bacterial contamination with Cronobacter sakazakii.
The recall was initiated after reports of sickness and deaths connected to the contamination, and Abbott is now facing a U.S. Department of Justice criminal investigation.
If your infant developed NEC after being fed Similac or Enfamil formula, you may be eligible to pursue a lawsuit for financial compensation.
Here are the types of damages that can be recovered in a baby formula lawsuit:
- Past and future medical expenses to treat your child’s injuries
- Past and future pain and suffering resulting from your child’s injuries, both physically and mentally
- Pain and Suffering
- Emotional Distress
- Loss of love, affection, care, companionship
- Punitive damages, when available
Recoverable Compensation
If your infant developed necrotizing enterocolitis (NEC) after being fed Similac or Enfamil formula in a neonatal intensive care unit, you may be entitled to recover compensation for various damages.
Past and future medical expenses to treat your child's injuries can be a significant part of the recovery. This includes the costs of ongoing medical care, surgeries, and treatments.
Explore further: Duty of Due Care

Pain and suffering resulting from your child's injuries, both physically and mentally, can also be recovered. This can include the emotional distress caused by your child's condition.
Other recoverable damages include loss of love, affection, care, and companionship. This acknowledges the impact on your family's quality of life.
Punitive damages, when available, can also be sought. These are meant to punish the responsible parties for their actions.
Here's a breakdown of the recoverable damages:
- Past and future medical expenses
- Past and future pain and suffering
- Emotional Distress
- Loss of love, affection, care, companionship
- Punitive damages (when available)
Has Been Recalled
Similac has not been recalled specifically for NEC risks, but it was involved in a larger Abbott baby formula recall in 2022.
Abbott issued a recall for products manufactured at its Sturgis plant, which included some Similac baby formula.
The recalls began in February 2022 due to reports of sickness and deaths connected to potential bacterial contamination with Cronobacter sakazakii.
Babies became ill after consuming Similac and other Abbott formulas, and some died.
Abbott now faces a U.S. Department of Justice criminal investigation because of the contamination at its Sturgis plant.
A dedicated team of lawyers is available to help you navigate the complex process of pursuing a lawsuit.
Investigation and Ruling
The investigation and ruling process has been a significant part of the Abbott Labs lawsuit. On August 7, 2024, the Honorable Sunil R. Harjani of the United States District Court for the Northern District of Illinois denied Abbott's motion to dismiss, allowing key derivative claims to move forward.
Abbott's motion to dismiss was specifically denied for two claims: breach of fiduciary duty for failure to oversee the manufacturing and sale of infant formula and violations of Section 10(b) of the Exchange Act and SEC Rule 10b-5. The court's decision allowed these claims to proceed.
In a separate ruling, the court also denied Abbott's motion to reconsider its August 7, 2024 motion to dismiss on November 12, 2024.
A fresh viewpoint: Title 7 Lawsuit
Verdict: $495 Million
A jury ordered Abbott Laboratories to pay $495 million in compensation and damages.
This verdict was the result of a lawsuit that claimed Abbott failed to warn about the risk of a bowel disease associated with its formula for premature infants.

Abbott says it disagrees with the verdict.
The company's formula was found to increase the risk of a bowel disease, which is a serious concern for parents of premature babies.
The amount of $495 million is a significant sum, and it's clear that the jury was serious about holding Abbott accountable.
Abbott Laboratories is a well-established company with a long history of producing baby formula, including Similac.
You might enjoy: Legal Document Subject a and B
Important Ruling for Investors
On August 7, 2024, the Honorable Sunil R. Harjani of the United States District Court for the Northern District of Illinois denied Abbott's motion to dismiss, allowing key derivative claims to move forward. This was a significant ruling for investors, as it allowed the case to proceed against Abbott.
Abbott Investors Secure Important Ruling
The court's decision was a major win for investors, as it permitted a claim for breach of fiduciary duty for failure to oversee the manufacturing and sale of infant formula to go forward.
For more insights, see: Pdiddy Court Case

A key aspect of this ruling was the court's denial of Abbott's motion to dismiss, which means that the company will have to defend itself against these claims. This can be a time-consuming and costly process for companies like Abbott.
Important Dates
Here are some important dates related to this case:
- August 7, 2024: The court denied Abbott's motion to dismiss.
- November 12, 2024: The court denied Abbott's motion to reconsider its August 7, 2024 motion to dismiss.
- February 14, 2025: The court largely denied a motion to stay by a Special Litigation Committee of Abbott's Board.
These dates highlight the ongoing nature of this case and the importance of staying up to date with the latest developments.
Shareholders and Leadership
A powerful union pension fund is among the shareholders taking aim at Abbott Laboratories' leadership in a derivative lawsuit.
The lawsuit accuses Abbott and its executives of insider trading amid misconduct related to its baby formula business.
Abbott shareholders have filed a derivative lawsuit against the company's leadership, including accusations of violating federal securities law.
The lawsuit seeks to hold Abbott's board of directors accountable for the baby formula contamination that led to a nationwide shortage in 2022.
A unique perspective: Abbott Labs Leadership
Cohen Milstein is co-lead counsel in the lawsuit, which was filed on behalf of the company against its leadership.
A consolidated complaint was filed in In re Abbott Laboratories Infant Formula Shareholder Derivative Litigation, a massive shareholder derivative lawsuit brought against Abbott Laboratories' Board of Directors.
The lawsuit is related to Abbott's manufacture, sale, and recall of contaminated infant formula.
Explore further: Celsius Holdings Shareholder Lawsuit
Enfamil Recall
Enfamil lawsuits are being filed against Mead Johnson, the manufacturer of Enfamil baby formula. Enfamil may have slightly different baby formula ingredients than Similac, but products made with cow’s milk share the same potential risk for causing NEC in preterm infants.
Mead Johnson is the next largest manufacturer of baby formula in the US, accounting for 40% of the market share. Abbott Laboratories, the manufacturer of Similac, holds a slightly larger share of the market at 47%.
The baby formula lawsuit multidistrict litigation in Illinois was formed by judges, and almost all of the first lawsuits that moved to the MDL were Similac lawsuits.
Readers also liked: Abbott Labs Market Cap
Qualification and Filing
To qualify for a Similac lawsuit, your child must have developed necrotizing enterocolitis (NEC) after consuming formula that contained cow's milk protein, and they must have been born prematurely or with a low birth weight.
These criteria also apply to Enfamil lawsuits and potentially other cow's milk formulas as well. Your child was most likely fed Similac while recovering in a hospital neonatal intensive care unit or after being discharged.
If you believe your child meets these qualifications, it's recommended to contact a lawyer for a free case evaluation to determine if you qualify for a Similac lawsuit.
To file a Similac lawsuit, hiring an experienced lawyer is highly recommended. They can help walk you through the complicated process of getting compensation for your baby's sickness or death from Similac-induced NEC.
Here are the steps to file a Similac lawsuit:
- Seek a free consultation with a baby formula lawsuit lawyer.
- Your lawyer will file your Similac lawsuit.
- Your lawyer will collect all evidence to help strengthen your claim against Abbott.
- Your lawyer will walk you through any necessary court filings.
- Your lawyer will argue your case in court or negotiate a settlement on your behalf.
See If You Qualify
To see if you qualify for a baby formula lawsuit, you'll want to review the criteria set forth by our legal partners. If your child developed necrotizing enterocolitis (NEC), consumed formula containing cow's milk protein, and was born prematurely or with a low birth weight, you may be entitled to compensation.

Our partners tell us that babies were most likely fed Similac while recovering in a hospital neonatal intensive care unit or after being discharged. This is why it's essential to contact our legal partners for a free case evaluation to determine if your child's specific case qualifies.
You'll need to provide information about your child's medical history and the formula they were fed. Our partners will review this information to determine if you qualify for a lawsuit.
Here are the key criteria to qualify for a baby formula lawsuit:
- Your child developed necrotizing enterocolitis (NEC)
- Your child consumed formula that contained cow’s milk protein
- Your child was born prematurely or with a low birth weight
If you meet these criteria, you may be eligible for compensation for financial and emotional damages, including pain and suffering.
How to File
Filing a lawsuit can be a daunting task, but it doesn't have to be.
To file a Similac lawsuit, you should hire an experienced lawyer instead of going it alone. This is because baby formula lawsuits are complex and now part of a mass tort and multidistrict litigation.

You can start by seeking a free consultation with a baby formula lawsuit lawyer. This will give you a chance to discuss your case and understand the process.
Your lawyer will take care of filing your Similac lawsuit, collecting evidence to strengthen your claim, and walking you through any necessary court filings.
In fact, our legal partners have over 20 years of experience in fighting for plaintiffs harmed through the negligence of powerful corporations.
Here are the steps your lawyer will take to help you through the process:
- File your Similac lawsuit
- Collect all evidence to help strengthen your claim against Abbott
- Walk you through any necessary court filings
- Argue your case in court or negotiate a settlement on your behalf
Having an experienced product liability lawyer can make a huge difference in your case. They have the knowledge and resources to take on big corporations like Abbott.
Latest Updates and Perspectives
As of September 2025, 760 Similac and Enfamil lawsuits are pending multidistrict litigation (MDL) in the Northern District of Illinois.
The main defendant in these lawsuits is Abbott Laboratories, the maker of Similac cow’s milk baby formulas.
Worth a look: Fisher Investments Lawsuits
According to Similac lawsuits, Abbott knew about the risk of necrotizing enterocolitis and failed to warn the public.
Premature babies have an underdeveloped digestive system, making it difficult for them to digest formulas that aren't as easy to digest as breast milk.
MDL 3026 is the multidistrict litigation number assigned to these lawsuits, which is being overseen by U.S. District Judge Rebecca Pallmeyer.
Frequently Asked Questions
What is the Abbott nutrition problem?
Abbott Nutrition faced a major recall in 2022 due to contamination issues with their infant formula, which led to serious illnesses in four U.S. infants. The recall was prompted by four cases of bacterial contamination, including Cronobacter sakazakii and Salmonella Newport.
What is the Abbott Nutrition Court case?
A mother's child developed NEC after being fed Abbott's premature infant formula in 2021, leading to a $495 million court verdict in Missouri state court. The case involves a lawsuit against Abbott Nutrition over its infant formula product.
Featured Images: pexels.com

